Viewing Study NCT03294694


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2025-12-31 @ 10:25 AM
Study NCT ID: NCT03294694
Status: TERMINATED
Last Update Posted: 2025-05-31
First Post: 2017-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module